Last edition
News about "Nor Ursodeoxycholic Acid (NorUDCA) Tablets 500 mg "
Shilpa Medicare Secures CDSCO Approval for NorUDCA Tablets in NAFLD Treatment
Shilpa Medicare Ltd has received approval from India's Central Drugs Standard Control Organization (CDSCO) for Nor Ursodeoxycholic Acid (NorUDCA) Tablets 500 mg for the treatment of Non-Alcoholic Fatty Liver Disease (NAFLD).
Nor Ursodeoxycholic Acid (NorUDCA) Tablets 500 Mg | 16/08/2025 | By Dineshwori | 227
We use our own and third party cookies to produce statistical information and show you personalized advertising by analyzing your browsing, according to our COOKIES POLICY. If you continue visiting our Site, you accept its use.
More information: Privacy Policy
pharmaindustrial-india.com - Professional magazine for pharma industry suppliers and lab technology - CEDRO members